Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders

Inhibition of the proinflammatory cytokine tumor necrosis factor alpha (TNFα) has been utilized as a treatment strategy for a variety of immune-mediated inflammatory disorders (IMID), including rheumatoid arthritis, Crohn’s disease and psoriasis. A wide array of biologic therapies targeting the TNFα...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Jordan T., Elman, Scott A., Merola, Joseph F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Rheumatologic Skin Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033307/
https://www.ncbi.nlm.nih.gov/pubmed/33842651
http://dx.doi.org/10.21037/atm-20-5552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033307/
https://www.ncbi.nlm.nih.gov/pubmed/33842651
http://dx.doi.org/10.21037/atm-20-5552

Ejemplares similares